March 2, 2024

Wound Care Market Size To Hit USD 35.33 Billion By 2032

The wound care market size was valued at USD 23.57 billion in 2023 and is expected to reach USD 35.33 billion by 2032, growing at a CAGR of 4.40% from 2023 to 2032.

Wound Care Market Size 2023 To 2032

Key Takeaways

  • North America contributed more than 46% of revenue share in 2022.
  • Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By application, the chronic segment has held the largest market share of 75% in 2022.
  • By application, the acute segment is anticipated to grow at a remarkable CAGR of 5.1% between 2023 and 2032.
  • By end-use, the hospital segment generated over 39% of revenue share in 2022.
  • By end-use, the home care segment is expected to expand at the fastest CAGR over the projected period.
  • By product, the advanced wound dressing segment generated over 34% of revenue share in 2022.
  • By product, the surgical wound care segment is expected to expand at the fastest CAGR over the projected period.
  • By mode of purchase, the prescribed segment generated over 65% of revenue share in 2022.
  • By mode of purchase, the non-prescribed (OTC) segment is expected to expand at the fastest CAGR over the projected period.

The wound care market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market

The study offers intricate dynamics about different aspects of the global wound care market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global wound care market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/3616

Wound Care Market Scope

Report CoverageDetails
Market Size in 2023USD 23.57 Billion
Market Size by 2032USD 35.33 Billion
Growth Rate from 2023 to 2032CAGR of 4.40%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Application, By End-use, By Product, and By Mode of Purchase
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read Also: Blood Culture Test Market Size To Surpass USD 16.31 Bn By 2032

This study covers an elaborate segmentation of the global wound care market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global wound care market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.

Wound Care Market Players

  • 3M Company
  • Smith & Nephew plc
  • Johnson & Johnson
  • Mölnlycke Health Care
  • Coloplast A/S
  • ConvaTec Group plc
  • B. Braun Melsungen AG
  • Medtronic plc
  • Acelity L.P. Inc.
  • Integra LifeSciences Corporation
  • Ethicon, Inc. (a subsidiary of Johnson & Johnson)
  • Derma Sciences, Inc. (acquired by Integra LifeSciences)
  • Misonix, Inc.
  • Organogenesis Holdings Inc.
  • Hollister Incorporated

Segments Covered in the Report

By Application

  • Chronic
  • Acute

By End-use

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Physician’s Office
  • Nursing Homes
  • Others

By Product

  • Advanced Wound Dressing
  • Surgical Wound Care
  • Traditional Wound Care
  • Wound Therapy Devices

By Mode of Purchase

  • Prescribed
  • Non-prescribed (OTC)

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

The research methodology acquire by analysts for assemble the global wound care market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global wound care market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Wound Care Market 

5.1. COVID-19 Landscape: Wound Care Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Wound Care Market, By Application

8.1. Wound Care Market, by Application, 2023-2032

8.1.1. Chronic

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Acute

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Wound Care Market, By End-use

9.1. Wound Care Market, by End-use, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Specialty Clinics

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Home Healthcare

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Physician’s Office

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Nursing Homes

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Wound Care Market, By Product 

10.1. Wound Care Market, by Product, 2023-2032

10.1.1. Advanced Wound Dressing

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Surgical Wound Care

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Traditional Wound Care

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Wound Therapy Devices

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Wound Care Market, By Mode of Purchase 

11.1. Wound Care Market, by Mode of Purchase, 2023-2032

11.1.1. Prescribed

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Non-prescribed (OTC)

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Wound Care Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.2. Market Revenue and Forecast, by End-use (2020-2032)

12.1.3. Market Revenue and Forecast, by Product (2020-2032)

12.1.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.2. Market Revenue and Forecast, by End-use (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.2. Market Revenue and Forecast, by End-use (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.2. Market Revenue and Forecast, by End-use (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.2. Market Revenue and Forecast, by End-use (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.2. Market Revenue and Forecast, by End-use (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Mode of Purchase (2020-2032)

Chapter 13. Company Profiles

13.1. 3M Company

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Smith & Nephew plc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Johnson & Johnson

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Mölnlycke Health Care

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Coloplast A/S

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. ConvaTec Group plc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. B. Braun Melsungen AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Medtronic plc

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Acelity L.P. Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Integra LifeSciences Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com